Integra LifeSciences to Present at the Following Four Conferences in March:
Citi Global Healthcare Conference
RBC Capital Markets' Healthcare Conference
Raymond James' Institutional Investors Conference
Barclays Capital Global Healthcare Conference
PLAINSBORO, N.J., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at four conferences in March as follows:
On Tuesday, March 1, 2011 at 3:30 PM ET, Mr. Stuart Essig, Chief Executive Officer of Integra, will present at the Citi 2011 Global Health Care Conference at the New York Hilton Hotel in New York City. There will be no webcast for this conference.
On Thursday, March 3, 2011 at 11:00 AM ET, Mr. Bob Paltridge, President, Extremity Reconstruction, will present at the RBC Capital Markets' Healthcare Conference at the New York Palace Hotel in New York City. A live webcast will be available via a link on the investor relations section on our corporate website, www.integralife.com.
Mr. Jack Henneman, Chief Financial Officer, will present at the following conferences:
- Wednesday, March 9, 2011 at 10:25 AM ET at the Raymond James Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida; and
- Wednesday, March 16, 2011 at 8:00 AM ET at the Barclays Capital Global Healthcare Conference at the Loews Hotel in Miami, Florida. There will be no webcast for the above two conferences.
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
IART-G
CONTACT: Integra LifeSciences Holdings Corporation
John B. Henneman, III
Executive Vice President
Finance and Administration
and Chief Financial Officer
(609) 275-0500
jack.henneman@integralife.com
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@integralife.com